A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

Eva Hellström‐Lindberg, Nina Gulbrandsen, Greger Lindberg, +17

British Journal of Haematology

Hematological MalignancyImmunohematologyLaboratory HematologyBone Marrow FailureValidated Decision Model +13

Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects

Charlotte Schwab, Annemarie Gabrysch, Peter Olbrich, +77

Journal of Allergy and Clinical Immunology

Clinical ImmunologyAllergyLymphocyte DevelopmentMedicineImmunodeficiencies +10

Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

Petter Woll, Una Kjällquist, Onima Chowdhury, +45

Cancer Cell

Hematological MalignancyBone Marrow FailureMyelodysplastic SyndromesMedicineMyeloid Neoplasia +7

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

Satu Mustjoki, Marja Ekblom, T. Petteri Arstila, +17

Leukemia

MedicineMalignant Blood DisorderImmunologyImmune Checkpoint InhibitorCell Biology +3

Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients

Eva Hellström-Lindberg, Tomas Ahlgren, Yves Béguin, +16

Blood

Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome

Martin Jädersten, Luca Malcovati, Ingunn Dybedal, +7

Journal of Clinical Oncology

Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders

Asbjørg Stray‐Pedersen, Hanne Sørmo Sorte, Pubudu Samarakoon, +90

Journal of Allergy and Clinical Immunology

Primary ImmunodeficiencyMendelian DisorderAutoimmune DiseaseMedicineImmunology +7

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF

Martin Jädersten, Scott Montgomery, Ingunn Dybedal, +2

Blood

Tumor necrosis factor (TNF)–mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells

Ingunn Dybedal, David Bryder, Anna Fossum, +2

Blood

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Jason Gotlib, Andreas Reiter, Deepti Radia, +21

Nature Medicine